Should Echocardiographic Evaluation Be Performed Routinely in the First 72 Hours in Extremely Low Birth Weight Babies?

Yıl: 2021 Cilt: 27 Sayı: 2 Sayfa Aralığı: 175 - 180 Metin Dili: İngilizce DOI: 10.21613/GORM.2020-1168 İndeks Tarihi: 07-02-2022

Should Echocardiographic Evaluation Be Performed Routinely in the First 72 Hours in Extremely Low Birth Weight Babies?

Öz:
OBJECTIVE: Hemodynamically significant patent ductus arteriosus is resulting in severe mortality and morbidity in infants with extremely low birth weight. In our study, we aimed to evaluate the necessity of performing routine echocardiography in the first 72 hours in extremely low birth weight infants. STUDY DESIGN: This study was planned retrospectively. Between June 2016 and December 2018, 36 patients diagnosed with hemodynamically significant patent ductus arteriosus who were hospitalized in the neonatal intensive care unit, with ≤28 gestational weeks or ≤1000g were included in this study. These babies were routinely performed echocardiography for patent ductus arteriosus between 24-72 hours, although they were asymptomatic in the period from June 2016 to December 2017 (n=23). Between January 2018 and December 2018, patients without patent ductus arteriosus symptoms were expected to complete 72 hours for routine patent ductus arteriosus screening (n=13). The patients were divided into 2 groups as the early echocardiography group (n=23) and the late echocardiography group (n=13). In the presence of at least one of the clinical signs of systemic hypo perfusion and/or pulmonary hyper perfusion, symptomatic patent ductus arteriosus was accepted and closure treatment was applied with ibuprofen (n=23) or paracetamol (n=5). While the two groups were compared in terms of demographic features, echocardiography findings, and the state of taking closure therapy, patients receiving closure therapy were compared in terms of mortality and premature morbidity. RESULTS: The mean birth weight of 36 patients was 855±241 g, and the mean gestational age was 26.4±2.1 gestational weeks. It was observed that the two groups were similar in terms of demographic characteristics. Although the findings of echocardiography and treatment rates were similar between the two groups, it was observed that the echocardiography group had earlier closure treatment (p=0.03). In patients receiving closure treatment, performing early (n=17) and late (n=11) echocardiography showed no statistical difference in the long-term results. CONCLUSION: Performing early echocardiography without symptoms in infants with extremely low birth weight may provoke the clinician to give patent ductus arteriosus closure treatment earlier. In infants with extremely low birth weight, unnecessary closure treatment can be prevented by closely monitoring the symptoms of patent ductus arteriosus and performing echocardiography when necessary.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Gillam-Krakauer M, Reese J. Diagnosis and management of patent ductus arteriosus. Neoreviews. 2018;19(7):e394- e402. Doi: 10.1542/neo.19-7-e394.
  • 2. Noori S, McCoy M, Friedlich P, Bright B, Gottipati V, Seri I, et al. Failure of ductus arteriosus closure is associated with increased mortality in preterm infants. Pediatrics. 2009;123(1):e138-44. Doi: 10.1542/peds. 2008-2418.
  • 3. Havranek T, Rahimi M, Hall H, Armbrecht E. Feeding preterm neonates with patent ductus arteriosus (PDA): intestinal blood flow characteristics and clinical outcomes. J Matern Fetal Neonatal Med. 2015;28(5):52630. Doi: 10.3109/14767058.2014.923395.
  • 4. Kaempf JW, Wu YX, Kaempf AJ, Kaempf AM, Wang L, Grunkemeier G. What happens when the patent ductus arteriosus is treated less aggressively in very low birth weight infants? J Perinatol. 2012;32(5):344-8. Doi: 10.1038/jp.2011.102.
  • 5. Evans N, Kluckow M. Early ductal shunting and intraventricular haemorrhage in ventilated preterm infants. Arch Dis Child Fetal Neonatal Ed. 1996;75(3):183-6. Doi: 10.1136/fn.75.3.f183.
  • 6. Kluckow M, Jeffery M, Gill A, Evans N. A randomised placebo-controlled trial of early treatment of the patent ductus arteriosus. Arch Dis Child Fetal Neonatal Ed. 2014;99(2):F99-F104. Doi: 10.1136/archdischild-2013- 304695.
  • 7. Benitz WE; Committee on Fetus and Newborn, American Academy of Pediatrics. Pediatrics. 2016;137(1): e20153730. Doi: 10.1542/peds.2015-3730.
  • 8. Koch J, Hensley G, Roy L, Brown S, Ramaciotti C, Rosenfeld CR. Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1000 grams or less. Pediatrics. 2006;117(4):1113-21. Doi: 10.1542/peds.2005-1528.
  • 9. Köksal N, Aygün C, Uras N. Turkish Neonatal Society guideline on the management of patent ductus arteriosus in preterm infants. Turk Pediatri Ars. 2018;53(Suppl 1):S76-S87. Doi: 10.5152/TurkPediatriArs.2018.01808.
  • 10. Clyman RI, Liebowitz M, Kaempf J, Erdeve O, Bulbul A, Håkansson S et al. PDA-TOLERATE (PDA: TO LEave it alone or Respond And Treat Early) Trial Investigators. PDA-TOLERATE Trial: An exploratory randomized controlled trial of treatment of moderate-to-large patent ductus arteriosus at 1 week of age. J Pediatr. 2019;205:41- 48.e6. Doi: 10.1016/j.jpeds.2018.09.012.
  • 11. Harling S, Hansen-Pupp I, Baigi A, Pesonen E. Echocardiographic prediction of patent ductus arteriosus in need of therapeutic intervention. Acta Paediatr. 2011;100(2):231-5. Doi: 10.1111/j.1651-2227.2010. 02027.x.
  • 12. Oncel MY, Erdeve O. Oral medications regarding their safety and efficacy in the management of patent ductus arteriosus. World J Clin Pediatr. 2016;5(1):75-81. Doi: 10.5409/wjcp.v5.i1.75.
  • 13. Oncel MY, Erdeve O. Safety of therapeutics used in management of patent ductus arteriosus in preterm infants. Current Drug Safety. 2015;10(2):106-12. Doi: 10.2174/ 1574886309999141030142847.
  • 14. Sellmer A, Bjerre JV, Schmidt MR, McNamara PJ, Hjortdal VE, Høst B et al. Morbidity and mortality in preterm neonates with patent ductus arteriosus on day 3. Arch Dis Child Fetal Neonatal Ed. 2013;98(6):F505-10. Doi: 10.1136/archdischild-2013-303816.
  • 15. Cooke L, Steer P, Woodgate P. Indomethacin for asymptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev. 2003;(2):CD003745. Doi: 10.1002/14651858.CD003745.
  • 16. Fowlie PW, Davis PG, McGuire W. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev. 2010;2010(7):CD000174. Doi: 10.1002/14651858.CD 000174.pub2.
  • 17. Benitz WE. Treatment of persistent patent ductus arteriosus in preterm infants: time to accept the null hypothesis? J Perinatol. 2010; 30(4):241-52. Doi: 10.1038/jp.2010.3.
  • 18. Seo ES, Sung SI, Ahn SY, Chang YS, Park WS. Changes in serum creatinine levels and natural evolution of acute kidney injury with conservative management of hemodynamically significant patent ductus arteriosus in extremely preterm infants at 23-26 weeks of gestation. J Clin Med. 2020;9(3):699. Doi: 10.3390/jcm9030699.
  • 19. Babla K, Sandeep S, Kulkarni A. A clinical and echocardiographic approach to evaluation of patent ductus arteriosus in preterm infants. J Paediatr Child Health. 2020; 30(4):129-34. Doi: 10.1016/j.paed.2020.01.003.
  • 20. Howell EA, Stone J, Kleinman LC, Inamdar S, Matseoane S, Chassin MR. Approaching NIH Guideline Recom - mended Care for Maternal-Infant Health: Clinical failures to use recommended antenatal corticosteroids. Matern Child Health J. 2010;14(3):430-6. Doi: 10.1007/s10995- 009-0480-3.
  • 21. Sardar SK, Saha AK, Majhi B, Chatterjee S. Prediction of ductus closure and development of adverse clinical outcome by functional echocardiography in very low birth weight newborn. J Neonatal Perinatal Med. 2020;13(1): 31-7. Doi: 10.3233/NPM-190229.
  • 22. Bell EF, Acarregui MJ. Restricted versus liberal water intake for preventing morbidity and mortality in preterm infants. Cochrane Database of Systematic Reviews 2014; 2014(12):CD000503. Doi: 10.1002/14651858.CD000 503.pub3.
  • 23. Kluckow M, Jeffery M, Gill A, Evans N. A randomised placebo-controlled trial of early treatment of the patent ductus arteriosus. Arch Dis Child Fetal Neonatal Ed. 2014;99(2):F99-F104. Doi: 10.1136/archdischild-2013- 304695.
  • 24. Ohlsson A, Shah SS. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev. 2020;1(1): CD004213. Doi: 10.1002/14651858.CD004213.pub5.
APA COLAK R, Alkan Özdemir S, yangın ergon e, KULALI F, Kalkanlı O, Gokmen Yildirim T, yılmazer m, Zihni C, Calkavur S (2021). Should Echocardiographic Evaluation Be Performed Routinely in the First 72 Hours in Extremely Low Birth Weight Babies?. , 175 - 180. 10.21613/GORM.2020-1168
Chicago COLAK RUYA,Alkan Özdemir Senem,yangın ergon ezgi,KULALI Ferit,Kalkanlı Oğuz Han,Gokmen Yildirim Tulin,yılmazer murat muhtar,Zihni Cüneyt,Calkavur Sebnem Should Echocardiographic Evaluation Be Performed Routinely in the First 72 Hours in Extremely Low Birth Weight Babies?. (2021): 175 - 180. 10.21613/GORM.2020-1168
MLA COLAK RUYA,Alkan Özdemir Senem,yangın ergon ezgi,KULALI Ferit,Kalkanlı Oğuz Han,Gokmen Yildirim Tulin,yılmazer murat muhtar,Zihni Cüneyt,Calkavur Sebnem Should Echocardiographic Evaluation Be Performed Routinely in the First 72 Hours in Extremely Low Birth Weight Babies?. , 2021, ss.175 - 180. 10.21613/GORM.2020-1168
AMA COLAK R,Alkan Özdemir S,yangın ergon e,KULALI F,Kalkanlı O,Gokmen Yildirim T,yılmazer m,Zihni C,Calkavur S Should Echocardiographic Evaluation Be Performed Routinely in the First 72 Hours in Extremely Low Birth Weight Babies?. . 2021; 175 - 180. 10.21613/GORM.2020-1168
Vancouver COLAK R,Alkan Özdemir S,yangın ergon e,KULALI F,Kalkanlı O,Gokmen Yildirim T,yılmazer m,Zihni C,Calkavur S Should Echocardiographic Evaluation Be Performed Routinely in the First 72 Hours in Extremely Low Birth Weight Babies?. . 2021; 175 - 180. 10.21613/GORM.2020-1168
IEEE COLAK R,Alkan Özdemir S,yangın ergon e,KULALI F,Kalkanlı O,Gokmen Yildirim T,yılmazer m,Zihni C,Calkavur S "Should Echocardiographic Evaluation Be Performed Routinely in the First 72 Hours in Extremely Low Birth Weight Babies?." , ss.175 - 180, 2021. 10.21613/GORM.2020-1168
ISNAD COLAK, RUYA vd. "Should Echocardiographic Evaluation Be Performed Routinely in the First 72 Hours in Extremely Low Birth Weight Babies?". (2021), 175-180. https://doi.org/10.21613/GORM.2020-1168
APA COLAK R, Alkan Özdemir S, yangın ergon e, KULALI F, Kalkanlı O, Gokmen Yildirim T, yılmazer m, Zihni C, Calkavur S (2021). Should Echocardiographic Evaluation Be Performed Routinely in the First 72 Hours in Extremely Low Birth Weight Babies?. GORM:Gynecology Obstetrics & Reproductive Medicine, 27(2), 175 - 180. 10.21613/GORM.2020-1168
Chicago COLAK RUYA,Alkan Özdemir Senem,yangın ergon ezgi,KULALI Ferit,Kalkanlı Oğuz Han,Gokmen Yildirim Tulin,yılmazer murat muhtar,Zihni Cüneyt,Calkavur Sebnem Should Echocardiographic Evaluation Be Performed Routinely in the First 72 Hours in Extremely Low Birth Weight Babies?. GORM:Gynecology Obstetrics & Reproductive Medicine 27, no.2 (2021): 175 - 180. 10.21613/GORM.2020-1168
MLA COLAK RUYA,Alkan Özdemir Senem,yangın ergon ezgi,KULALI Ferit,Kalkanlı Oğuz Han,Gokmen Yildirim Tulin,yılmazer murat muhtar,Zihni Cüneyt,Calkavur Sebnem Should Echocardiographic Evaluation Be Performed Routinely in the First 72 Hours in Extremely Low Birth Weight Babies?. GORM:Gynecology Obstetrics & Reproductive Medicine, vol.27, no.2, 2021, ss.175 - 180. 10.21613/GORM.2020-1168
AMA COLAK R,Alkan Özdemir S,yangın ergon e,KULALI F,Kalkanlı O,Gokmen Yildirim T,yılmazer m,Zihni C,Calkavur S Should Echocardiographic Evaluation Be Performed Routinely in the First 72 Hours in Extremely Low Birth Weight Babies?. GORM:Gynecology Obstetrics & Reproductive Medicine. 2021; 27(2): 175 - 180. 10.21613/GORM.2020-1168
Vancouver COLAK R,Alkan Özdemir S,yangın ergon e,KULALI F,Kalkanlı O,Gokmen Yildirim T,yılmazer m,Zihni C,Calkavur S Should Echocardiographic Evaluation Be Performed Routinely in the First 72 Hours in Extremely Low Birth Weight Babies?. GORM:Gynecology Obstetrics & Reproductive Medicine. 2021; 27(2): 175 - 180. 10.21613/GORM.2020-1168
IEEE COLAK R,Alkan Özdemir S,yangın ergon e,KULALI F,Kalkanlı O,Gokmen Yildirim T,yılmazer m,Zihni C,Calkavur S "Should Echocardiographic Evaluation Be Performed Routinely in the First 72 Hours in Extremely Low Birth Weight Babies?." GORM:Gynecology Obstetrics & Reproductive Medicine, 27, ss.175 - 180, 2021. 10.21613/GORM.2020-1168
ISNAD COLAK, RUYA vd. "Should Echocardiographic Evaluation Be Performed Routinely in the First 72 Hours in Extremely Low Birth Weight Babies?". GORM:Gynecology Obstetrics & Reproductive Medicine 27/2 (2021), 175-180. https://doi.org/10.21613/GORM.2020-1168